BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21697062)

  • 1. Etanercept, childhood and long-term safety: a case of five years treatment.
    Mazzotta A; Saraceno R; Esposito M; Chimenti S
    Eur J Dermatol; 2011; 21(5):776-7. PubMed ID: 21697062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
    Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept for the treatment of psoriasis and psoriatic arthritis.
    Gottlieb AB
    Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE; Clarke S
    J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Our experience with etanercept in the treatment of psoriasis.
    Kokelj F; Miertusova Tothova S; Patamia M; Trevisan G
    Acta Dermatovenerol Croat; 2006; 14(4):241-5. PubMed ID: 17311738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term experience with etanercept in psoriatic arthritis patients: a 3-year observational study.
    Mazzotta A; Esposito M; Schipani C; Chimenti S
    J Dermatolog Treat; 2009; 20(6):354-8. PubMed ID: 19954392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
    Rokhsar C; Rabhan N; Cohen SR
    J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.
    Leonardi C; Strober B; Gottlieb AB; Elewski BE; Ortonne JP; van de Kerkhof P; Chiou CF; Dunn M; Jahreis A
    J Drugs Dermatol; 2010 Aug; 9(8):928-37. PubMed ID: 20684143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medical uses and side effects of etanercept with a focus on cutaneous disease.
    Scheinfeld N
    J Drugs Dermatol; 2004; 3(6):653-9. PubMed ID: 15624748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept treatment patterns in managed-care patients with psoriasis or psoriatic arthritis.
    Thayer S; Watson C; Song R; Globe DR; Harrison DJ
    J Med Econ; 2010; 13(2):228-35. PubMed ID: 20459298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When there is no single best biological agent: psoriasis and psoriatic arthritis in the same patient responding to two different biological agents.
    Adişen E; Karaca F; Gürer MA
    Clin Exp Dermatol; 2008 Mar; 33(2):164-6. PubMed ID: 18257837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
    Zanni M; Missale G; Santilli D; Di Nuzzo S
    Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
    Mease PJ
    Skin Therapy Lett; 2003 Jan; 8(1):1-4. PubMed ID: 12728284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biologics in the treatment of psoriasis].
    Dissemond J; Grabbe S
    MMW Fortschr Med; 2006 Sep; 148(38):42-4. PubMed ID: 17036963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.
    Pelekanou A; Kanni T; Savva A; Mouktaroudi M; Raftogiannis M; Kotsaki A; Giamarellos-Bourboulis EJ
    Exp Dermatol; 2010 Jun; 19(6):538-40. PubMed ID: 19758320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.